Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2025 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungen
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to The Report
Fundraising

Altana

Altana Raises $200M in Series C

2018
Founded
200+
Employees
New York, NY
Updated July 22, 2024
2 min read

Quick Facts

Altana Raises $200M in Series C


Altana has successfully raised $200M in a Series C at a $1B valuation led by Thomas Tull's US Innovative Technology Fund.


Company Overview


Altana is a Enterprise Software company headquartered in New York, NY, founded in 2018 with 200+ employees.


Empowers governments and enterprises with intelligent supply chain mapping and analytics


Fundraising Details


  • Amount Raised: $200M
  • Round Type: Series C
  • Valuation: $1B
  • Date: 2024-07-22
  • Investors: Thomas Tull's US Innovative Technology Fund

About Altana


Empowers governments and enterprises with intelligent supply chain mapping and analytics The company is positioned in the Enterprise Software sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: New York, NY
  • Founded: 2018
  • Team Size: 200+
  • Industry: Enterprise Software

What This Means


This funding round demonstrates strong investor confidence in Altana's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Enterprise Software sector continues to attract significant investment as companies innovate to meet evolving market demands. Altana's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1B valuation marks an important milestone for Altana, positioning the company among notable players in the Enterprise Software industry.


Looking Ahead


With this new capital, Altana is well-positioned to execute on its growth strategy and continue building innovative solutions in the Enterprise Software space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-07-22. For more information about Altana, visit their headquarters at New York, NY.

Topics

Fundraising(2912)Enterprise Software(383)Series C(291)Altana

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million